Leadership

Dr. Marc Abreu

Founder, Chief Medical and Scientific Officer
Brain Tunnelgenix Technologies Corp.™

Innovator, medical doctor, physicist and academician, Dr. Abreu, of both Harvard Medical School and Yale University, is board certified in Anesthesiology as well as Ophthalmology. At Yale, he recently served as clinical faculty in the Department of Anesthesiology and was a post-doctoral fellow and faculty in the Department of Ophthalmology and Visual Sciences.

FDA Clears the World’s First Noninvasive Continuous  Temperature Monitoring System discovered by Yale Researcher, Dr. Marc Abreu, his groundbreaking discovery, called the “Brain Temperature Tunnel” captures brain wave patterns that lead to a thermal signature, and this can help medical professionals detect early-stage infection and a host of neurodegenerative diseases.

the-founder-dr-marc-abreu-btt
the-founder-dr-marc-abreu-btt

Professional Accomplishments and Achievements:

While at Yale, he discovered the brain thermal tunnel, which for the first time in history enabled non-invasive, continuous measurement of human brain temperature.  Dr. Abreu is one of the world’s foremost experts on body thermal energy, having studied brain thermodynamics for two decades and inventing technologies that resulted in dozens of patents. He developed the BTT™ Abreu  700 system, an FDA-cleared, computer-based device with a micro sensor that measures brain temperature. The BTT™ Abreu  700  provides the most accurate and true brain temperature without corrective factors found in all other digital and infrared thermometer. Brain Tunnelgenix Technologies Corp.™, a MedTech company, utilizes advanced sensors, software, and artificial intelligence that uniquely captures brain thermodynamic signatures.

While at Harvard University, at the behest of the US Government’s Department of Defense, AirForce division, he developed an advanced cold laser system; patented an Opto-electromagnetic tonometric system licensed to Nestlé’s pharmaceutical unit, Alcon Laboratories; at Abreu discovered the Radiation Signature of Glucose within the mid-infrared wavelength irradiated as thermal energy from the body. Dr. Abreu also developed the first FDA-cleared computer system for continuous temperature measurement during surgery, intensive care, and general patient monitoring in association with ASUS Corporation.

Jose Fernandez

Chief Executive Officer

Jose Fernandez is CEO and a board member at Brain Tunnelgenix Technologies Corp™ (BTT™ Corp.), is a MedTech company concentrating on services and solutions based on combining the power of Brain Thermodynamics, Internet of Things and Predictive Models using Artificial Intelligence.

He was BBVA Securities’ CEO in New York, BBVA Director for Latin America, BBVA Asset and Liability Management in Madrid, Spain, Director and Head Representative for BBVA in Brazil, and Director for BBVA Brazil Investment Bank. Jose sat on the advisory board of ABBI (Brazilian Association of International Banks). In 2016, he was a partner at Global Driver Technologies, an energy efficiency company, based in Sao Paulo, Brazil, responsible for managing the company’s finances including capital funding and strategic planning. Fernandez holds a Master’s in International Management from Thunderbird School of Global Management in Arizona, an MBA from ESADE in Spain and a B.A. in Business Administration from Clark University, in Massachusetts.

Fernandez has over 32 years of financial market experience in the USA, Latin America and Southern Europe. His work in the international finance world has focused on capital markets, asset and liability management, and wealth management.

jose-fernandez-btt-CEO
jose-fernandez-btt-CEO

Rob Mogel

Director of Operations and Director of Health Services

Rob Mogel is BTT’s Director of Operations and Director of Health Services.  As Director of Operations, Mogel is responsible for all operational components of the company’s medical and corporate affairs.  In addition, as Director of Health Services, he assures the smooth flow of all relations between patient, BTT’s medical team, and other medical providers. He is fluent in French, Spanish, and proficient in Portuguese and German.

Mogel has over thirty years of experience in the medical field working for both American and foreign based companies.  Rob received his Master’s in International Affairs from Columbia University and did his studies in both the United States and France.

rob-mogel-btt-director-operations
rob-mogel-btt-director-operations